Price Target Changed • May 03
Price target decreased by 10% to CN¥28.61 Down from CN¥31.92, the current price target is provided by 1 analyst. New target price is 36% above last closing price of CN¥21.00. Stock is down 29% over the past year. The company is forecast to post earnings per share of CN¥0.47 next year compared to a net loss per share of CN¥1.84 last year. Announcement • Apr 29
Goodwill E-Health Info Co., Ltd., Annual General Meeting, May 27, 2026 Goodwill E-Health Info Co., Ltd., Annual General Meeting, May 27, 2026, at 14:30 China Standard Time. Location: 1F, Building 28, Yard No. 28, No. 8, Dongbeiwang West Road, Haidian District, Beijing China Announcement • Mar 30
Goodwill E-Health Info Co., Ltd. to Report Q1, 2026 Results on Apr 29, 2026 Goodwill E-Health Info Co., Ltd. announced that they will report Q1, 2026 results on Apr 29, 2026 Reported Earnings • Mar 05
Full year 2025 earnings: EPS and revenues miss analyst expectations Full year 2025 results: CN¥1.84 loss per share (improved from CN¥1.86 loss in FY 2024). Revenue: CN¥407.7m (down 31% from FY 2024). Net loss: CN¥252.8m (loss narrowed 1.3% from FY 2024). Revenue missed analyst estimates by 32%. Earnings per share (EPS) also missed analyst estimates significantly. Revenue is forecast to grow 33% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Healthcare Services industry in Asia. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 95 percentage points per year, which is a significant difference in performance. Announcement • Dec 26
Goodwill E-Health Info Co., Ltd. to Report Fiscal Year 2025 Results on Apr 24, 2026 Goodwill E-Health Info Co., Ltd. announced that they will report fiscal year 2025 results on Apr 24, 2026 New Risk • Dec 18
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-CN¥183m free cash flow). Minor Risk Share price has been volatile over the past 3 months (8.5% average weekly change). Board Change • Dec 14
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Yun Wang was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Oct 30
Third quarter 2025 earnings released: CN¥0.41 loss per share (vs CN¥0.10 loss in 3Q 2024) Third quarter 2025 results: CN¥0.41 loss per share (further deteriorated from CN¥0.10 loss in 3Q 2024). Revenue: CN¥111.2m (down 37% from 3Q 2024). Net loss: CN¥57.3m (loss widened 316% from 3Q 2024). Revenue is forecast to grow 30% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Healthcare Services industry in Asia. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 115 percentage points per year, which is a significant difference in performance. Announcement • Sep 30
Goodwill E-Health Info Co., Ltd. to Report Q3, 2025 Results on Oct 30, 2025 Goodwill E-Health Info Co., Ltd. announced that they will report Q3, 2025 results on Oct 30, 2025 Price Target Changed • Aug 31
Price target increased by 7.3% to CN¥34.24 Up from CN¥31.92, the current price target is an average from 2 analysts. New target price is approximately in line with last closing price of CN¥33.15. Stock is up 91% over the past year. The company is forecast to post earnings per share of CN¥0.53 next year compared to a net loss per share of CN¥1.86 last year. New Risk • Jul 30
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company. Announcement • Jun 30
Goodwill E-Health Info Co., Ltd. to Report First Half, 2025 Results on Aug 29, 2025 Goodwill E-Health Info Co., Ltd. announced that they will report first half, 2025 results on Aug 29, 2025 Announcement • Apr 30
Goodwill E-Health Info Co., Ltd., Annual General Meeting, May 27, 2025 Goodwill E-Health Info Co., Ltd., Annual General Meeting, May 27, 2025, at 14:30 China Standard Time. Location: 1F, Tower 28, Yard No. 8, Dongbeiwang West Road, Haidian District, Beijing China Announcement • Mar 28
Goodwill E-Health Info Co., Ltd. to Report Q1, 2025 Results on Apr 29, 2025 Goodwill E-Health Info Co., Ltd. announced that they will report Q1, 2025 results on Apr 29, 2025 Reported Earnings • Mar 02
Full year 2024 earnings: EPS and revenues miss analyst expectations Full year 2024 results: CN¥1.09 loss per share (down from CN¥0.31 profit in FY 2023). Revenue: CN¥600.7m (down 14% from FY 2023). Net loss: CN¥150.0m (down 453% from profit in FY 2023). Revenue missed analyst estimates by 22%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 29% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Healthcare Services industry in Asia. Over the last 3 years on average, earnings per share has fallen by 61% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings. Announcement • Dec 27
Goodwill E-Health Info Co., Ltd. to Report Fiscal Year 2024 Results on Apr 29, 2025 Goodwill E-Health Info Co., Ltd. announced that they will report fiscal year 2024 results on Apr 29, 2025 Reported Earnings • Oct 30
Third quarter 2024 earnings released: CN¥0.10 loss per share (vs CN¥0.29 profit in 3Q 2023) Third quarter 2024 results: CN¥0.10 loss per share (down from CN¥0.29 profit in 3Q 2023). Revenue: CN¥175.3m (down 29% from 3Q 2023). Net loss: CN¥13.8m (down 134% from profit in 3Q 2023). Revenue is forecast to grow 29% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Healthcare Services industry in Asia. Announcement • Sep 30
Goodwill E-Health Info Co., Ltd. to Report Q3, 2024 Results on Oct 30, 2024 Goodwill E-Health Info Co., Ltd. announced that they will report Q3, 2024 results on Oct 30, 2024 New Risk • Sep 27
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.3% average weekly change). Profit margins are more than 30% lower than last year (5.4% net profit margin). Valuation Update With 7 Day Price Move • Sep 27
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to CN¥18.99, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 20x in the Healthcare Services industry in Asia. Total loss to shareholders of 40% over the past year. Price Target Changed • Aug 29
Price target decreased by 14% to CN¥29.48 Down from CN¥34.36, the current price target is an average from 3 analysts. New target price is 74% above last closing price of CN¥16.90. Stock is down 51% over the past year. The company is forecast to post earnings per share of CN¥0.70 for next year compared to CN¥0.31 last year. Reported Earnings • Aug 20
Second quarter 2024 earnings released: CN¥0.11 loss per share (vs CN¥0.004 loss in 2Q 2023) Second quarter 2024 results: CN¥0.11 loss per share (further deteriorated from CN¥0.004 loss in 2Q 2023). Revenue: CN¥177.9m (down 3.5% from 2Q 2023). Net loss: CN¥15.6m (loss widened CN¥15.1m from 2Q 2023). Revenue is forecast to grow 27% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Healthcare Services industry in Asia. New Risk • Aug 06
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company. Announcement • Jun 28
Goodwill E-Health Info Co., Ltd. to Report First Half, 2024 Results on Aug 20, 2024 Goodwill E-Health Info Co., Ltd. announced that they will report first half, 2024 results on Aug 20, 2024 Valuation Update With 7 Day Price Move • May 23
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to CN¥26.29, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 21x in the Healthcare Services industry in Asia. Total loss to shareholders of 30% over the past year. Announcement • Apr 29
Goodwill E-Health Info Co., Ltd., Annual General Meeting, May 21, 2024 Goodwill E-Health Info Co., Ltd., Annual General Meeting, May 21, 2024, at 14:30 China Standard Time. Location: 1F, 1st Section, No. 7, Shangdi Kaituo Road, Haidian District, Beijing China Reported Earnings • Apr 28
First quarter 2024 earnings released: CN¥0.09 loss per share (vs CN¥0.16 loss in 1Q 2023) First quarter 2024 results: CN¥0.09 loss per share (improved from CN¥0.16 loss in 1Q 2023). Revenue: CN¥122.6m (up 14% from 1Q 2023). Net loss: CN¥11.9m (loss narrowed 48% from 1Q 2023). Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Healthcare Services industry in Asia. Valuation Update With 7 Day Price Move • Apr 15
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to CN¥21.85, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 24x in the Healthcare Services industry in Asia. Total loss to shareholders of 52% over the past year. Announcement • Mar 30
Goodwill E-Health Info Co., Ltd. to Report Q1, 2024 Results on Apr 27, 2024 Goodwill E-Health Info Co., Ltd. announced that they will report Q1, 2024 results on Apr 27, 2024 Reported Earnings • Feb 27
Full year 2023 earnings: EPS and revenues miss analyst expectations Full year 2023 results: EPS: CN¥0.33 (down from CN¥0.49 in FY 2022). Revenue: CN¥703.2m (down 1.9% from FY 2022). Net income: CN¥45.1m (down 34% from FY 2022). Profit margin: 6.4% (down from 9.5% in FY 2022). The decrease in margin was primarily driven by lower revenue. Revenue missed analyst estimates by 21%. Earnings per share (EPS) also missed analyst estimates by 54%. Revenue is forecast to grow 22% p.a. on average during the next 3 years, compared to a 21% growth forecast for the Healthcare Services industry in Asia. New Risk • Feb 08
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (31% accrual ratio). Minor Risk Share price has been volatile over the past 3 months (8.1% average weekly change). Valuation Update With 7 Day Price Move • Feb 01
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to CN¥21.99, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 26x in the Healthcare Services industry in Asia. Total loss to shareholders of 34% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥40.39 per share. Valuation Update With 7 Day Price Move • Oct 30
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to CN¥32.33, the stock trades at a forward P/E ratio of 34x. Average forward P/E is 28x in the Healthcare Services industry in Asia. Total returns to shareholders of 13% over the past year. Reported Earnings • Aug 29
Second quarter 2023 earnings released: CN¥0.004 loss per share (vs CN¥0.015 profit in 2Q 2022) Second quarter 2023 results: CN¥0.004 loss per share (down from CN¥0.015 profit in 2Q 2022). Revenue: CN¥184.5m (up 20% from 2Q 2022). Net loss: CN¥501.8k (down 125% from profit in 2Q 2022). Revenue is forecast to grow 27% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Healthcare Services industry in Asia. Announcement • Aug 23
Goodwill E-Health Info Co., Ltd. (SHSE:688246) announces an Equity Buyback for CNY 50 million worth of its shares. Goodwill E-Health Info Co., Ltd. (SHSE:688246) announces a share repurchase program. Under the program, the company will repurchase up to CNY 50 million worth of its shares. The program will be valid till 12 months. New Risk • Aug 10
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (39% accrual ratio). Minor Risk Share price has been volatile over the past 3 months (6.2% average weekly change). Announcement • Jun 28
Goodwill E-Health Info Co., Ltd. to Report First Half, 2023 Results on Aug 26, 2023 Goodwill E-Health Info Co., Ltd. announced that they will report first half, 2023 results on Aug 26, 2023 Reported Earnings • Apr 29
First quarter 2023 earnings released: CN¥0.16 loss per share (vs CN¥0.20 loss in 1Q 2022) First quarter 2023 results: CN¥0.16 loss per share (improved from CN¥0.20 loss in 1Q 2022). Revenue: CN¥107.5m (up 9.7% from 1Q 2022). Net loss: CN¥22.7m (loss narrowed 19% from 1Q 2022). Revenue is forecast to grow 40% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Healthcare Services industry in Asia. Reported Earnings • Mar 01
Full year 2022 earnings: EPS and revenues miss analyst expectations Full year 2022 results: EPS: CN¥0.47. Revenue: CN¥695.7m (up 6.7% from FY 2021). Net income: CN¥64.3m (up 30% from FY 2021). Profit margin: 9.2% (up from 7.6% in FY 2021). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 20%. Earnings per share (EPS) also missed analyst estimates by 20%. Revenue is forecast to grow 38% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Healthcare Services industry in Asia. Valuation Update With 7 Day Price Move • Dec 06
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥33.21, the stock trades at a forward P/E ratio of 43x. Average forward P/E is 43x in the Healthcare Services industry in Asia. Valuation Update With 7 Day Price Move • Nov 10
Investor sentiment improved over the past week After last week's 19% share price gain to CN¥32.86, the stock trades at a forward P/E ratio of 30x. Average forward P/E is 29x in the Healthcare Services industry in Asia. Reported Earnings • Oct 30
Third quarter 2022 earnings released: EPS: CN¥0.16 (vs CN¥0.046 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.16 (up from CN¥0.046 in 3Q 2021). Revenue: CN¥203.4m (up 17% from 3Q 2021). Net income: CN¥27.3m (up 497% from 3Q 2021). Profit margin: 13% (up from 2.6% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 32% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Healthcare Services industry in Asia. Valuation Update With 7 Day Price Move • Oct 14
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥23.52, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 30x in the Healthcare Services industry in Asia. Reported Earnings • Aug 31
Second quarter 2022 earnings released: EPS: CN¥0.015 (vs CN¥0.20 loss in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.015 (up from CN¥0.20 loss in 2Q 2021). Revenue: CN¥153.9m (up 110% from 2Q 2021). Net income: CN¥2.04m (up CN¥22.2m from 2Q 2021). Profit margin: 1.3% (up from net loss in 2Q 2021). Over the next year, revenue is forecast to grow 57%, compared to a 20% growth forecast for the Healthcare Services industry in China. Reported Earnings • Apr 27
First quarter 2022 earnings released: CN¥0.20 loss per share (vs CN¥0.20 loss in 1Q 2021) First quarter 2022 results: CN¥0.20 loss per share (vs CN¥0.20 loss in 1Q 2021). Revenue: CN¥98.0m (up 34% from 1Q 2021). Net loss: CN¥27.9m (loss widened 38% from 1Q 2021). Over the next year, revenue is forecast to grow 52%, compared to a 18% growth forecast for the industry in China. Reported Earnings • Mar 04
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Full year 2021 results: EPS: CN¥0.46 (up from CN¥0.21 in FY 2020). Revenue: CN¥646.8m (up 22% from FY 2020). Net income: CN¥48.0m (up 126% from FY 2020). Profit margin: 7.4% (up from 4.0% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates.